Andrew Dagis - Concepedia

Author

Andrew Dagis

City Of Hope National Medical Center ORCID

Also Known As

A C Dagis, A Dagis, A. C. Dagis, A. Dagis, ANDREW C. DAGIS, Andrew C. Dagis, Andrew Dagis, Dagis, Andrew

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

City Of Hope National Medical Center City of Hope Stanford University Stanford Medicine

About

Andrew Dagis is an author at City Of Hope National Medical Center specializing in medicine, cell transplantation, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	838
2	Health Sciences	5	5	223
3	Blood Transplantation	2	2	242
4	Allergy	1	1	48
5	Cell Biology	1	1	20

Andrew Dagis

Publications

Citations

H-Index

Page 1

	Year	Citations
Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease Nelson J. Chao, G. Schmidt, Joyce C. Niland, New England Journal of Medicine	1993	262
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation Vinod Pullarkat, Suzette Blanchard, Bernard Tegtmeier, Bone Marrow Transplantation TransplantationMarrow TransplantationHeme HomeostasisBone Marrow FailureIron Overload	2008	203
Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer Elizabeth A. Peralta, Joshua D.I. Ellenhorn, Lawrence D. Wagman, The American Journal of Surgery Surgical OncologyContralateral Prophylactic MastectomyBreast OncologyMedicineBreast Cancer	2000	198
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Auayporn Nademanee, Irena Sniecinski, GM Schmidt, Journal of Clinical Oncology	1994	133
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission DS Snyder, AP Nademanee, MR O’Donnell, Leukemia Hematological MalignancyFirst Complete RemissionTransplantationMarrow TransplantationLong-term Follow-up	1999	108
Results of High-Dose Therapy and Autologous Bone Marrow/Stem Cell Transplantation During Remission in Poor-Risk Intermediate- and High-Grade Lymphoma: International Index High and High-Intermediate Risk Group Auayporn Nademanee, Arturo Molina, Margaret O’Donnell, Blood	1997	99
The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation John A. Zaia, Joel Y. Sun, Ghislaine Gallez‐Hawkins, Biology of Blood and Marrow Transplantation	2009	94
EXTENDED FOLLOW-UP IN 212 LONG-TERM ALLOGENEIC BONE MARROW TRANSPLANT SURVIVORS ISSUES OF QUALITY OF LIFE G. Schmidt, Joyce C. Niland, Stephen J. Forman, Transplantation	1993	93
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. NJ Chao, Parker Pm, JC Niland, PubMed	1996	93
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies Joseph Rosenthal, Jeffrey Y.C. Wong, Anthony S. Stein, Blood	2010	90

Page 1